Sarepta Therapeutics Inc (SRPT) financials · $2.34B cap
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Sarepta Therapeutics Inc (SRPT) $2.34B cap.
| Line | Q2 2026 | Q1 2026 |
|---|---|---|
| Revenue | $401.3M | $730.8M |
| Operating Income | $13.3M | $358.4M |
| Net Income | -$4.89M | $331.0M |
| EPS (Diluted) | -$0.05 | $2.88 |
| Line | Q2 2026 | Q1 2026 |
|---|---|---|
| Total Assets | $3.19B | $3.18B |
| Current Assets | $2.22B | $2.31B |
| Cash & Equivalents | $571.1M | $464.4M |
| Inventory | $904.3M | $1.00B |
| PP&E | $326.0M | $336.2M |
| Total Liabilities | $1.66B | $1.67B |
| Current Liabilities | $502.9M | $499.2M |
| Long-term Debt | $847.6M | $838.2M |
| Total Debt | $847.6M† | $838.2M† |
| Shareholders' Equity | $1.53B | $1.51B |
| Retained Earnings | -$4.55B | -$4.55B |
† Total Debt: Derived from long-term debt only (no total or short-term debt stored).
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$205.5M | -$205.8M |
| CapEx | $102.0M | $137.0M |
| Investing Cash Flow | $69.6M | $755.6M |
| Financing Cash Flow | -$168.3M | $124.8M |
| Net Change in Cash | -$304.2M | $674.6M |
| Free Cash Flow | -$307.5M | -$342.7M |
FAQ
What is SRPT P/E and revenue?
Sarepta Therapeutics Inc (SRPT) $2.34B cap.
What is SRPT revenue?
Sarepta Therapeutics Inc last cached revenue is $401.3M (Q2 2026).
Is SRPT profitable?
Sarepta Therapeutics Inc last cached net income is -$4.89M (Q2 2026).
What are SRPT total assets?
Sarepta Therapeutics Inc last cached total assets are $3.19B (Q2 2026).
What is SRPT free cash flow?
Sarepta Therapeutics Inc last cached free cash flow is -$307.5M (FY2025).
Not investment advice. Cached statements, not a live tape.